A woman aged 56 was admitted with swelling of the lower limbs and the abdomen which had developed slowly. Previously she had been well; she had never smoked and drank little alcohol. Cytological and microbiological examination of ascitic¯uid revealed nothing abnormal. An echocardiogram, however, showed dilated and poorly contracting cardiac chambers with moderate mitral and tricuspid regurgitation. Idiopathic dilated cardiomyopathy was diagnosed and the patient was started on diuretics and an angiotensin converting enzyme inhibitor.
In view of the gross ascites, serum Ca 125 was checked and proved to be greatly raised at 2150 IU/mL (normal <38). Although no malignant cells had been found in the ascitic¯uid, a gynaecological opinion was sought. On vaginal examination, there were no adnexal masses palpable. A CT scan of the pelvis was normal. Transabdominal ultrasound revealed a normal right ovary but the left ovary was not clearly visualized. Because the cause of the raised serum Ca 125 remained unclear, exploratory laparotomy was decided upon. However, in the interim the patient responded to heart failure treatment with almost complete resolution of ascites and peripheral oedema. Serum Ca 125 fell to 240 IU/ mL. Importantly, a transvaginal ultrasound showed normal ovaries. The laparotomy was therefore cancelled and the patient continued on heart failure treatment. When reviewed 2 months later, she was well and serum Ca 125 had returned to normal (31 IU/mL). 4 years later she returned with gross ascites and peripheral oedema. This time serum Ca 125 was 4020 IU/ mL, but cytological and microbiological examination of ascitic¯uid was again normal, as was a transvaginal ultrasound. She responded well to intravenous diuretics and uid restriction. Maintenance doses of frusemide and enalapril were increased. 3 months later she was clinically euvolaemic and serum Ca 125 was normal.
COMMENT
In a postmenopausal female with ascites, raised serum Ca 125 is frequently perceived as a diagnostic marker of ovarian cancer. This is a misconception. Although the Ca 125 antigen is present on more than 80% of malignant epithelial ovarian tissue of non-mucinous type, it is also found on both healthy and malignant cells of mesothelial (pleural, pericardial, peritoneal, endometrial) and nonmesothelial (amniotic membrane, tracheobronchial and cervical epithelium) origin. Raised serum Ca 125 levels have therefore been reported in various conditions involving these cells, including pleural and pericardial effusions and ascites 1 .
The mechanism of raised serum Ca 125 in ascites is not fully understood. In culture, peritoneal mesothelial cells shed ®ve times more Ca 125 than ovarian cancer cells 2 , and one theory is that the antigen enters the blood via lymphatic absorption of ascites 3 . Peritoneal stretching seems relevant, since serum Ca 125 falls rapidly after paracentesis 4 . In patients with cirrhosis an additional factor could be low clearance of Ca 125 by the liver 5 ; and in those with malignant ascites, in®ltration of the peritoneal membrane could contribute.
Serum Ca 125 is therefore a non-speci®c marker. Currently it is used for monitoring response to treatment and detection of recurrent disease in patients with known ovarian cancer 6 , and as an aid to differential diagnosis of adnexal masses 7 . Its value in screening for ovarian cancer is being investigated 8 .
Our case illustrates that, for good management decisions, a rational order of investigations is crucial. In this patient, during investigation of ascites, serum Ca 125 was measured before pelvic ultrasound examination. This happened on two occasions and, unfortunately, each time this led to diagnostic confusion and concerns about ovarian cancer. On the ®rst occasion surgery was scheduled, and this would have been particularly hazardous in view of the true cause of the ascites.
The exclusion of metastatic ovarian cancer as a cause of ascites is of great importance in view of the bene®ts of chemotherapy in advanced disease 9 . We suggest that every woman with ®rst-onset ascites should have a pelvic ultrasound scan (preferably transvaginal) unless lymphoma cells are found in the ascitic¯uid. Although not speci®cally evaluated in patients with ascites, a normal pelvic ultrasound scan in a symptom-free postmenopausal woman with raised serum Ca 125 indicates an extremely low risk of ovarian cancer 10 . Pelvic ultrasound should also be considered in patients with an unexplained worsening of ascites the cause of which had been established previously. If an adnexal mass is identi®ed, serum Ca 125 may be a useful diagnostic aid; in the absence of a mass, misinterpretation of a raised serum Ca 125 can lead to unnecessary and hazardous interventions. The vas deferens is seldom palpated during routine physical examination, though absence of the vas has important implications.
A missing vas

CASE HISTORY
A man of 45 with moderate obesity came for routine vasectomy under local anaesthesia after an initial outpatient consultation at which no physical examination had been performed. The right vas was successfully ligated; the surgeon then explored the other side but had to abandon the operation because of persistent patient discomfort and inability to ®nd the vas. At a second operation, performed under general anaesthesia, absence of the left vas was con®rmed. An ultrasound scan subsequently demonstrated absence of the ipsilateral kidney. COMMENT John Hunter ®rst described absence of the vas deferens in a cadaver in 1737 1 , and an association with ipsilateral renal agenesis has been noted 2,3 . The reported prevalence of unilateral absence of the vas deferens is between 0.06% and 0.8% 4,5 . Unilateral renal agenesis is less common, with an estimated prevalence of 0.1% 6 . However, of patients with unilateral absence of the vas deferens, up to 80% have ipsilateral renal agenesis 4 . Even when the kidney is present, it may be affected by a wide range of anomalies such as ectopia, malrotation, fusion and polycystic disease. Abnormalities in the solitary contralateral kidney occur in nearly 10% of such patients, ranging from ureteric obstruction to vesicoureteric re¯ux 4 . In addition, ipsilateral absence of the adrenal gland has been reported in 15±25% of patients with renal agenesis 7 .
Developmentally the Wolf®an duct, which ultimately forms the vas deferens, is derived from the mesonephric duct. The ureteric bud which likewise develops from the mesonephric duct forms the ureter, renal pelvis, calyces, and collecting tubules. Thus congenital absence of the Wolf®an duct precludes formation of a ureteric bud and results in renal agenesis. As in the case presented, the testicle is usually present in patients with a congenitally absent vas, since the testis is derived from the genital fold and not the mesonephric duct.
This case highlights the dif®culties which may result from a congenitally absent vas deferens during vasectomy, which is increasingly performed as a day-case ambulant procedure in family planning clinics. We recommend that, when the vas cannot be felt on one side, on clinical examination, the patient should undergo scrotal exploration under general anaesthesia, to allow a thorough search before the vas is declared congenitally absent. All such patients should have imaging of the renal tracts. Because of the association between congenital absence of the vas deferens and defects in the cystic ®brosis transmembrane conductance regulator gene, these patients should also undergo genetic cystic ®brosis screening 8 .
Absence of the vas deferens may be a useful warning sign in patients with blunt abdominal trauma requiring emergency surgery. Such patients should be assumed to have ipsilateral renal agenesis until proved otherwise.
